Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check31 days agoChange DetectedThe webpage has updated its date references, removing older dates from March 2025 and adding new dates in April 2025. The status has also changed to 'Completed', indicating a significant update in the page's content.SummaryDifference0.7%
- Check39 days agoChange DetectedThe web page has been updated to reflect a new version of a clinical study, with the removal of specific details about the study's design and inclusion criteria, while retaining core information about the cohorts involved in the study.SummaryDifference24%
- Check46 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.2. The estimated last update posted has been removed.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has updated its recruiting status to 'Completed' and removed previous dates related to recruitment activities, indicating a shift in the recruitment phase.SummaryDifference1%
- Check82 days agoChange DetectedThe page has updated its status to 'Completed' and 'Recruiting' for a project in Gdańsk, Poland, with new dates indicating upcoming activities in February 2025.SummaryDifference2%
Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.